Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Aetna Inc (AET)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 69,637,976
  • Shares Outstanding, K 327,400
  • Annual Sales, $ 60,535 M
  • Annual Income, $ 1,904 M
  • 36-Month Beta 0.71
  • Price/Sales 1.15
  • Price/Cash Flow 17.10
  • Price/Book 3.75
  • Price/Earnings ttm 19.58
  • Earnings Per Share ttm 10.83
  • Most Recent Earnings 2.96 on 10/30/18
  • Next Earnings Date N/A
  • Annual Dividend & Yield 2.00 (0.00%)
  • Most Recent Dividend 0.500 on 10/23/18
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 11 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/18
See More
  • Average Estimate 1.81
  • Number of Estimates 9
  • High Estimate 1.92
  • Low Estimate 1.70
  • Prior Year 1.25
  • Growth Rate Est. (year over year) +44.80%

Price Performance

See More
Period Period Low Period High Performance
1-Month
194.39 +9.42%
on 10/29/18
213.36 -0.31%
on 11/28/18
+17.41 (+8.91%)
since 10/26/18
3-Month
194.27 +9.49%
on 10/26/18
213.36 -0.31%
on 11/28/18
+13.84 (+6.96%)
since 08/28/18
52-Week
166.88 +27.45%
on 04/02/18
213.36 -0.31%
on 11/28/18
+33.86 (+18.93%)
since 11/28/17

Most Recent Stories

More News
Pass it on: CVS CEO says the learning should never stop

Larry Merlo has learned a few things during nearly eight years as CEO of one of the nation's biggest drugstore chains — including that you shouldn't ever stop learning.

AET : 212.70 (+0.33%)
Asian shares fall on poor Chinese economic data

SINGAPORE (AP) — Asian markets tumbled on Friday after China reported weaker-than-expected economic data, stirring up worries about the state of the world's second largest economy.

AET : 212.70 (+0.33%)
NFLX : 272.49 (+3.69%)
AFL : 44.66 (+0.77%)
TLRD : 14.12 (+4.90%)
CVS and Delta fall while Aflac and General Electric jump

NEW YORK (AP) — Stocks that moved substantially or traded heavily Thursday:

AET : 212.70 (+0.33%)
KMB : 113.89 (-0.25%)
OXM : 70.50 (+1.59%)
AFL : 44.66 (+0.77%)
TLRD : 14.12 (+4.90%)
DAL : 53.08 (+1.32%)
McDermott Advises CVS Health Corp. on Aetna and WellCare Transactions

McDermott Will & Emery was one of several law firms to advise CVS Health Corp. on its approximately $70 billion cash and stock purchase of health insurer Aetna Inc., which closed on November 28, 2018....

AET : 212.70 (+0.33%)
Glenridge Health Announces New Board Member, Jeff Chaffkin

Glenridge Health announced today that Jeff Chaffkin of XMS Capital Partners has been appointed to the Board of Directors.

AET : 212.70 (+0.33%)
WellCare Completes Acquisition of Standalone Medicare Part D Prescription Drug Plan Business from Aetna

WellCare Health Plans, Inc. (NYSE: WCG) announced today, that on November 30, 2018, it closed its acquisition of Aetna Inc.'s standalone Medicare Part D prescription drug plans (the "Aetna Part D plans")....

AET : 212.70 (+0.33%)
WCG : 227.99 (-3.78%)
A.M. Best Affirms Credit Ratings of Aetna, Inc. and Its Subsidiaries; Affirms Credit Ratings of SilverScript Insurance Company

A.M. Best has affirmed the Financial Strength Rating (FSR) of A (Excellent) and the Long-Term Issuer Credit Ratings (Long-Term ICRs) of "a" of Aetna Life Insurance Company (ALIC) (Hartford,...

AET : 212.70 (+0.33%)
Research Report Identifies Equinix, Universal Electronics, LHC Group, Cohbar, Amgen, and Aetna with Renewed Outlook -- Fundamental Analysis, Calculating Forward Movement

In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors, traders, and shareholders of Equinix, Inc. (NASDAQ:EQIX),...

AET : 212.70 (+0.33%)
LHCG : 94.09 (-0.81%)
EQIX : 374.83 (+1.56%)
CWBR : 3.41 (-4.75%)
UEIC : 26.67 (+2.93%)
AMGN : 187.64 (-1.28%)
CVS Health Completes Acquisition of Aetna, Marking Start of Transforming Consumer Health Experience

CVS Health (NYSE: CVS), a company that is leading the transformation of health care, today announced that it has completed its acquisition of Aetna (NYSE: AET), establishing CVS Health as the nation's...

AET : 212.70 (+0.33%)
CVS : 69.56 (-1.60%)
WCG : 227.99 (-3.78%)
MEDNAX and Unit Unveil Incubator for Better Patient Results

MEDNAX (MD) and its radiology arm launch MDR-AI Incubator to develop products for better patient care.

AET : 212.70 (+0.33%)
MOH : 119.84 (-0.13%)
MD : 35.60 (+0.03%)
ANTM : 260.89 (-2.17%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 96% Buy and ranks in the Top 1% of all short term signal directions.

Longer term, the trend strength is Maximum. Long term indicators fully support a continuation of the trend.

The market is in highly overbought territory. Beware of a trend reversal.

See More Share

Trade AET with:

Business Summary

Aetna Inc. is one of the nation's leading diversified health care benefits companies, serving the people with information and resources to help them make better informed decisions about their health care. Aetna offers a broad range of traditional, voluntary and consumer-directed health insurance products...

See More

Key Turning Points

2nd Resistance Point 214.19
1st Resistance Point 213.44
Last Price 212.70
1st Support Level 211.87
2nd Support Level 211.05

See More

52-Week High 213.36
Last Price 212.70
Fibonacci 61.8% 195.61
Fibonacci 50% 190.12
Fibonacci 38.2% 184.64
52-Week Low 166.88

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar